Off-label TMS for optimization

TMS for Fibromyalgia and Chronic Pain

TMS for Fibromyalgia & Chronic Pain

What the Research Really Shows

As a physician, I regularly meet patients who have been living with fibromyalgia or chronic pain for years. Many have tried medications, physical therapy, supplements, injections, and lifestyle changes. Some experience partial relief. Many do not.

Transcranial Magnetic Stimulation (TMS) is not a miracle cure. But it is a legitimate, research-supported neuromodulation therapy that is increasingly being studied for fibromyalgia and centralized pain syndromes.

Here is what we currently know, based on the science.

Understanding Fibromyalgia as a Brain-Based Pain Condition

Fibromyalgia is not simply “muscle pain.” It is now widely understood as a disorder of central pain processing, sometimes referred to as central sensitization.

In fibromyalgia, the brain and spinal cord amplify pain signals. Functional imaging studies show altered activity in cortical regions involved in pain modulation, including the motor cortex and prefrontal cortex.

Because TMS works directly on these cortical networks, researchers have explored whether modulating brain activity could reduce pain intensity. TMS is FDA-cleared for depression and OCD. Its use in fibromyalgia and chronic pain is considered investigational, but there is growing clinical evidence supporting its potential benefit.

What Does the Research Show?
  1. Meta-Analysis Data
    • A 2022 systematic review and meta-analysis published in PubMed (PMID: 34542624) analyzed randomized controlled trials of repetitive TMS (rTMS) for fibromyalgia. The findings include:
      • Significant short-term reduction in pain compared to sham stimulation
      • Improvements in quality of life measures
      • Strongest results when high-frequency stimulation targeted the primary motor cortex (M1)
      • Effects most pronounced in the weeks following treatment
      • Importantly, results were more consistent for pain reduction than for fatigue or mood symptoms.
  2. Independent Patient Advocacy Perspective
    • The Fibromyalgia Research Foundation summarizes the current literature and notes that while TMS is not yet a standardized fibromyalgia treatment, accumulating evidence supports its role as a potential adjunctive therapy.
    • Similarly, other educational resources describe TMS as a promising non-drug intervention for centralized pain disorders.
Why Might TMS Help Chronic Pain?

In chronic pain conditions, including fibromyalgia, neuropathic pain, and centralized pain syndromes, the issue is often not tissue damage, but dysregulated neural circuitry.

TMS may:

  • Modulate cortical excitability
  • Improve descending pain inhibition
  • Reduce hyperactivity in pain amplification networks
  • Promote neuroplasticity

This is a brain-based intervention for a brain-mediated pain disorder.

How Effective Is It in Real Terms?

In clinical trials:

  • Pain scores often decrease modestly to moderately
  • Benefits are typically seen after multiple sessions (often 15–30 treatments)
  • Maintenance sessions may be required
  • Response varies between individuals

This is not universal pain elimination.
It is, for some patients, meaningful reduction and improved function.

Where TMS Fits in a Fibromyalgia Treatment Plan

In my view, TMS should be considered:

  • When conventional therapies have provided insufficient relief
  • When patients prefer to avoid long-term medication escalation
  • As part of a comprehensive care model that may include therapy, movement rehabilitation, and nervous system regulation strategies

TMS is not a replacement for holistic care.
It is a potential tool within it.

The Bottom Line

Fibromyalgia is complex. So is chronic pain. But TMS shows measurable short-term pain reduction in fibromyalgia

Neuromodulation through TMS represents a scientifically grounded, evolving option — one that aligns with our growing understanding that many chronic pain conditions originate in neural network dysregulation rather than peripheral tissue injury.

If you are exploring TMS for fibromyalgia or chronic pain, a thorough consultation with a physician experienced in neuromodulation is essential to determine whether it is appropriate for your specific presentation.

Dr. Zachary Demko, MD
About the Author

Dr. Zachary Demko is a dual-board certified Psychiatrist and co-owner of Transcend TMS. He lives in Franklin, TN with his family.


Comments

Leave a Reply

Discover more from

Subscribe now to keep reading and get access to the full archive.

Continue reading